Acute Myeloid Leukemia (AML)

All Ages · Both Sexes · All Stages

5-year relative survival

28.4%for this source population

95% confidence interval 28.1%–28.7%

All Ages · Both Sexes · All Stages

Relative survivalYears after diagnosis

Selected population 5-year: 28.4%

Shading: selected population’s 95% confidence interval. Lines connect published annual estimates.

SEER · 2000-2022 diagnoses

A population estimate, not a personal forecast.

Source population: Acute Myeloid Leukemia (AML)Captured September 2026 · Research preview